Melanoma
Conference Coverage
Merkel Cell Carcinoma Prognosis Linked to Vitamin D
Major Finding: Vitamin D deficiency was found in nearly two-thirds of a large group of patients with Merkel cell carcinoma, and their outcomes...
News
Tuberous Sclerosis Skin Lesions Improved on Everolimus
Major Finding: Of the patients on everolimus, 42% in EXIST-1 and 26% in EXIST-2 had significant improvements in their skin lesions, compared with...
News
Imaging Unwarranted in Primary Cutaneous Melanoma
Major Finding: Among the imaging modalities studied, the use of chest x-ray for staging primary cutaneous melanoma yielded true positives in 0.3%...
News
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
News
More Evidence Links Tanning Beds to Skin Cancer
Major Finding: Exposure to indoor tanning was associated with a 29% higher risk for basal cell carcinoma and a 67% higher risk for squamous cell...
News
Health Care Professionals Tank in Cancer Survey
Major Finding: Only 10% of health professionals and 20% of the public knew that cancer risk increases with age, but while 41% and 32% knew that...
News
Dual Kinase Therapy Slows BRAF-Mutated Metastatic Melanoma
Major Findings: Progression-free survival was 9.4 months using a combination of dabrafenib 150 mg and trametinib 2 mg as compared with 5.8 months...
News
SPECT/CT Before SLN Excision Improves Melanoma Survival
Major Finding: The local relapse rate in the SPECT/CT cohort was lower than in the SLNE alone cohort (6.8% vs. 23.8%, respectively).Data Source: A...
News
Medicare Okays Wound Plasma Gel for Clinical Trial Patients
Conference Coverage
Vemurafenib After Ipilimumab Linked to Rash
Major Finding: Four patients (25%) developed grade 3 maculopapular skin rash that histologically had features of a drug hypersensitivity rash.